Big Pharma says It Must Collaborate with Juniors to Revive Real Innovation
Innovation in the pharmaceutical industry has come a long way in the last few decades, but with the saturation of medical technology, a slowdown as is being witnessed now was definitely inevitable. Big pharmaceutical companies are suddenly looking to collaborate at all levels to spark innovation. Several companies have formed partnerships to advance new drug innovations including Medtronic plc (NYSE: MDT), Abbott Laboratories (NYSE: ABT), Zynerba Pharmaceuticals (NASDAQ: ZYNE), and Aequus ... Click here to view full article